Our Website Uses Cookies 

We and the third parties that provide content, functionality, or business services on our website may use cookies to collect information about your browsing activities in order to provide you with more relevant content and promotional materials, on and off the website, and help us understand your interests and improve the website.

For more information, please contact us or consult our Privacy Notice.

Your binder contains too many pages, the maximum is 40.

We are unable to add this page to your binder, please try again later.

This page has been added to your binder.

Allison Schiffman represents clients in a broad range of M&A transactions. Ms. Schiffman regularly supports both public and private strategic and private equity clients in both U.S. and cross-border acquisitions, sales, divestitures, carve-out transactions, minority investments, joint ventures and public company acquisitions across many industries.

  • Mavis Tire Express Services and West First Management Corp. in Mavis's acquisition by an investor group led by BayPine LP in partnership with TSG Consumer Partners LP and existing significant equity-holder West First Management, a holding company controlled by David and Stephen Sorbaro.
  • Mavis Tire Express Services in numerous add-on acquisitions, including its acquisition of Town Fair Tire Centers, a leading automotive tire retailer.
  • Adtalem in its pending $1.48 billion acquisition of Walden.
  • Astellas Pharma in its $2.7 billion acquisition of Audentes Therapeutics, Inc. (NASDAQ: BOLD).
  • Bayer AG in the sale of the Coppertone sun care business to Beiersdorf AG for $550 million and the Dr. Scholl's foot care business to Yellow Wood Partners for $585 million.
  • IFM Therapeutics:
    • in the sale of IFM’s NLRP3 antagonist programs to Novartis for up to $1.275 billion;
    • in the sale of IFM’s STING and NLRP3 agonist programs to BMS for up to $1.3 billion; and
    • in a collaboration and option transaction with Novartis in connection with cGAS/STING-related immunotherapies, with an option value of up to $840 million.
  • Emergent BioSolutions in its up to $735 million acquisition of Adapt Pharma and its product NARCAN.
  • Mavis Discount Tire in its merger with Express Oil Change & Tire Engineers, a Golden Gate Capital portfolio company, to create one of the largest U.S. automotive service platforms.
  • ONCAP in its acquisition and subsequent sale of Tecta, the nation's premier commercial roofing contractor, and in its acquisitions of AutoSource Motors, the largest U.S. branded title vehicle retailer and Enertech Holdings LLC, a leading provider of wireless infrastructure services to telecommunications carriers and tower owners throughout the Southern, Central and Pacific Northwest regions of the United States.
  • Sorbaro family and Mavis Discount Tire, one of the largest U.S. independent tire retailers, in the sale of a significant minority interest in Mavis to ONCAP Management Partners.
  • Fiberon in its $470 million sale to Fortune Brands Home & Security.
  • Resource Capital Corp. in the sale of its Northport Capital finance business to a partnership of CVC Credit and Coller Capital.
  • MidFirst Bank in its acquisitions of 1st Century Bancshares, Inc. (NASDAQ: FCTY) and Steele Street Bank & Trust.
  • Pharming Group N. V. on the acquisition of all North American commercialization rights to Ruconest® from Valeant.
  • Rogers Corporation in its acquisition of Griswold.
  • U.S. M&A counsel to Joy Global, Inc on its French-law governed acquisition of Montabert S.A.S. from Doosan Holding France S.A.S.